An IGFBP-3 blood test measures the main carrier protein that transports insulin-like growth factor 1 through your bloodstream, and it is almost always ordered alongside IGF-1 rather than on its own. Because that carrier protein rises and falls with growth hormone activity, it gives your care team a second, steadier view of an axis that is notoriously hard to measure directly. Most people meet this marker after a child’s growth slows down, after an adult reports unexplained fatigue and body composition changes, or during follow-up of a pituitary condition. In this article you will learn what the protein does, how the sample is collected, why reference ranges shift so much with age, what high and low results usually point to, and which findings deserve a prompt conversation with a clinician.
What the IGFBP-3 blood test actually measures
IGFBP-3 stands for insulin-like growth factor binding protein 3. It is a transport protein made mostly by your liver, and it is the most abundant of the six binding proteins that shuttle growth factors around the body. Roughly three quarters to nine tenths of the IGF-1 circulating in your blood at any moment is locked into a large complex with IGFBP-3 and a third partner called the acid-labile subunit.
A carrier, not a hormone
The distinction matters when you read your report. IGFBP-3 does not act on tissues the way growth hormone or thyroid hormone does. Instead it does three jobs: it keeps IGF-1 from being cleared by the kidneys within minutes, it releases IGF-1 gradually where tissues need it, and it restrains IGF-1 from over-stimulating cell growth. Researchers have also described IGF-independent effects, where the binding protein influences cell survival directly, but those actions are still being mapped and are not what a routine lab result reflects.
Why laboratories pair it with IGF-1
Growth hormone itself is released in short bursts, mostly overnight, so a single random measurement tells you very little. IGF-1 smooths those pulses out over hours. IGFBP-3 smooths them out even further, and it is less sensitive to a short fast or a missed meal than IGF-1 is. Reading the two together therefore gives a more stable picture than either alone. If you want the companion marker explained in the same depth, consult our IGF-1 blood test guide.
Why your doctor ordered this test
An IGFBP-3 measurement is rarely part of a general checkup panel. It is a targeted request, and knowing the reason behind it usually explains which direction your clinician expects the number to move.
In children and teenagers
The most common trigger is a growth curve that has flattened. Pediatric endocrinologists use IGF-1 and IGFBP-3 together as screening tools before committing a child to a growth hormone stimulation test, which takes several hours and requires repeated blood draws. According to Cleveland Clinic, both markers are used to help identify growth hormone deficiency, alongside the child’s measured growth increments over time. The binding protein is especially useful in very young children, where IGF-1 alone often reads low simply because levels are naturally low at that age.
In adults
Adults are usually tested for one of three reasons: suspected adult growth hormone deficiency after pituitary surgery, radiation, or head injury; suspected acromegaly, where a pituitary tumor produces too much growth hormone; or monitoring of an established condition already under treatment. Because pituitary disease rarely affects one hormone in isolation, the request often arrives with other pituitary-linked tests, and you may want to review our TSH blood test explanation and our cortisol blood test overview for context on the other axes that get checked at the same time.
How the sample is taken and what can move the number
The test itself is unremarkable: a standard venous blood draw from the arm, a few minutes, no special preparation in most laboratories. Some centers still ask for a morning sample or a short fast so the result can be compared cleanly with IGF-1 and glucose drawn at the same time, so follow the instructions your lab gives you rather than a general rule.
Factors that genuinely shift the result
- Age and pubertal stage, which are by far the strongest influences.
- Nutritional status, since prolonged low calorie or low protein intake suppresses the whole axis.
- Liver function, because the liver manufactures most circulating IGFBP-3.
- Kidney function, since impaired clearance can allow fragments of the protein to accumulate.
- Poorly controlled diabetes and severe illness, both of which blunt the axis.
- Estrogen therapy taken by mouth, which changes how the liver responds to growth hormone.
Nutrition deserves particular attention, because a low result driven by undernutrition looks nothing like a pituitary problem once other markers are read alongside it. Clinicians commonly cross-check protein status, and you can see how those markers behave in our albumin test results guide and our prealbumin blood level guide.
Assay differences are not an error
Different analyzers produce different absolute numbers for the same sample. That is why your report always carries its own reference interval, and why a value from one laboratory should not be compared directly with a value from another. If you are being followed over time, ask whether your samples are being run on the same platform.
Reading your result: units, ranges, and the age effect
IGFBP-3 is reported in micrograms per milliliter or in milligrams per liter, and increasingly as a standard deviation score, often written as SDS or z-score. The standard deviation score is the more informative figure: it tells you how far your value sits from the average for someone of your age and sex, so a score near zero is typical and a score below minus two is meaningfully low.
How levels behave across the lifespan
| Life stage | Typical pattern | What it means for interpretation |
|---|---|---|
| Infancy and early childhood | Lowest absolute values of life | Absolute numbers are unhelpful; the age-adjusted score is what counts |
| Mid childhood | Gradual, steady rise | A flat trend across two draws matters more than one value |
| Puberty | Peak of the entire lifespan | Pubertal stage, not birthday age, sets the expected range |
| Young adulthood | Settles below the pubertal peak | Stable baseline useful for later comparison |
| Middle age onward | Slow, continuous decline | A modestly low value can be age-appropriate rather than abnormal |
The IGF-1 to IGFBP-3 ratio
Some reports include a molar ratio of IGF-1 to IGFBP-3. The idea is straightforward: if most IGF-1 is bound, then the ratio hints at how much is free to act on tissues. It is a research-friendly figure that some clinics use when adjusting growth hormone doses, but it is not a stand-alone diagnostic threshold, and a ratio outside the printed range does not by itself indicate disease.
What a low IGFBP-3 result can mean
A low result is a signal to look at the whole axis, not a diagnosis on its own. The most clinically important explanation is growth hormone deficiency, where the pituitary gland produces too little growth hormone and both IGF-1 and IGFBP-3 fall together. In children this shows up as a growth rate that has slowed relative to peers; in adults it shows up more subtly as reduced energy, increased abdominal fat, and lower bone density.
Common non-pituitary explanations
Undernutrition, chronic liver disease, advanced kidney disease, untreated celiac disease, poorly controlled diabetes, and any severe systemic illness can all push the number down without any pituitary problem at all. This is why clinicians look at liver and kidney panels in the same sitting. Our alkaline phosphatase results guide and our creatinine test results guide cover two of the checks that most often accompany an unexpectedly low binding protein.
What a high IGFBP-3 result can mean
Elevated IGFBP-3 most often reflects excess growth hormone. In adults that condition is acromegaly, which develops slowly and shows up as enlarging hands and feet, coarsening facial features, joint pain, and sometimes new headaches or vision changes. In children and adolescents whose growth plates have not closed, the same excess produces gigantism.
Important nuances
Mayo Clinic notes that IGF-1 is the primary screening test for acromegaly and is confirmed with an oral glucose tolerance test, because IGF-1 can also be raised in other conditions. IGFBP-3 behaves similarly: it supports the picture rather than settling it. Elevated values are also seen normally during puberty and pregnancy, and can appear when metabolic hormones are disturbed. If insulin resistance is part of the discussion, our insulin blood test guide and our fasting glucose test results guide explain the markers your clinician is likely to read next.
When to see a doctor
An out-of-range value on a printout is not an emergency, but some combinations of symptom and result should not wait for a routine follow-up appointment. Use the guide below to judge urgency, and bring the actual report to the visit rather than a remembered number.
| Situation | Suggested timing |
|---|---|
| Slightly out of range, no symptoms, otherwise healthy | Discuss at your next scheduled appointment |
| A child whose height has fallen off their growth curve | Ask for a pediatric endocrinology referral within weeks |
| Rings or shoes no longer fit, jaw or facial changes | Book an appointment promptly rather than waiting |
| New persistent headaches or changes in peripheral vision | Seek medical assessment without delay |
| Unintended weight loss with a markedly low result | Contact your clinician within days |
| Known pituitary condition with a shifting trend | Follow the monitoring interval your specialist set |
Whatever the timing, resist the temptation to interpret a single figure in isolation. A structured approach to reading any panel is set out in our guide to understanding lab results.
Latest scientific advances
Research from the past three years has been less about replacing this marker and more about reading it more precisely. Based on studies retrieved from PubMed, several findings stand out for patients.
A clearer reference picture for children on growth hormone
A 2026 study in a leading endocrinology journal built sex-specific reference ranges for bioactive IGF-1 in more than five hundred healthy children, then compared them with total IGF-1 and the IGF-1 to IGFBP-3 ratio in children receiving growth hormone therapy. Bioactive means the fraction actually able to signal to cells, as opposed to the total amount present. Most treated children had bioactive levels inside the normal range even when their total IGF-1 looked high, and the authors suggest bioactive measurement may help fine-tune dosing in selected patients. What this means for you: if your child’s total IGF-1 reads above the expected band during treatment, that alone does not mean the dose is wrong, and specialist centers now have better tools for checking.
Exercise can nudge the growth axis in short-stature children
A 2025 controlled intervention published in a pediatrics journal followed short-stature children through twenty-four weeks of supervised jumping exercise. The exercise group gained more height and showed a more favorable balance between IGF-1 and its binding protein than the comparison groups, while morning growth hormone itself did not change. The design was non-randomized and the numbers were small, so this is promising rather than settled. What this means for you: structured physical activity is a reasonable part of a growth plan discussed with a pediatrician, but it is not a substitute for evaluating an underlying cause.
An unexpected role in chest pain assessment
A 2025 study in a European cardiology journal tested whether the change in IGFBP-3 over the first two hours could help emergency clinicians decide which chest pain patients, who do not meet the criteria for a heart attack, still need imaging or stress testing. The marker added modest predictive value on top of standard clinical assessment. What this means for you: this is early work in a research setting and will not appear on your local lab menu, but it illustrates that a protein long filed under growth is being examined well outside endocrinology.
Searching for a steadier growth hormone marker
A 2025 population study measured a protein called soluble alpha klotho in nearly nine hundred adults and compared how much it varied with age, weight, kidney function, and fasting relative to IGF-1 and IGFBP-3. Klotho appeared less affected by those everyday variables, which is why the authors proposed it as a possible future complement in growth hormone conditions. A separate 2026 study of a Brazilian family with an inherited growth hormone deficiency found that the machinery releasing IGF-1 from its binding proteins is itself altered in lifelong deficiency, which helps explain why two people with similar IGF-1 numbers can look clinically different. What this means for you: your result is a snapshot of a system, and clinicians increasingly interpret it as one, rather than reading a single number as a verdict.
Glossary
| Term | Definition |
|---|---|
| IGFBP-3 | Insulin-like growth factor binding protein 3, the main carrier protein for IGF-1 in the blood, made mostly by the liver. |
| IGF-1 | Insulin-like growth factor 1, the messenger the liver releases in response to growth hormone. It carries out most of growth hormone’s effects on tissue. |
| Growth hormone | A pituitary hormone released in short bursts that drives growth in children and helps regulate body composition in adults. |
| Acid-labile subunit | A third protein that joins IGF-1 and IGFBP-3 to form a large, slow-clearing complex in the circulation. |
| Standard deviation score | Also written SDS or z-score. A figure showing how far a value sits from the average for a person’s age and sex. |
| Acromegaly | A condition in adults caused by excess growth hormone, usually from a benign pituitary tumor, producing gradual enlargement of hands, feet, and facial features. |
| Growth hormone deficiency | A shortage of growth hormone that slows growth in children and affects energy, muscle, and bone in adults. |
| Molar ratio | A comparison of the number of IGF-1 molecules to IGFBP-3 molecules, used as a rough indicator of how much IGF-1 is available to tissues. |
| Assay | The laboratory method used to measure a substance. Different assays give different absolute values for the same sample. |
| Pituitary gland | A small gland at the base of the brain that controls growth hormone and several other hormone systems. |
Frequently asked questions
Do I need to fast before an IGFBP-3 test?
Usually not. This binding protein is more stable across the day than IGF-1, so many laboratories accept a non-fasting sample. That said, the test is frequently drawn together with glucose, insulin, or a lipid panel, and those companion tests may require fasting. The safest approach is to follow the written instructions your ordering clinic gives you and to ask when you book the appointment rather than assuming. If you have already eaten and were supposed to fast, tell the phlebotomist instead of proceeding, since a note on the sample is far better than an uninterpretable result.
What does a high IGFBP-3 mean in a child?
In a child, a value above the printed range is often simply pubertal. Levels of this protein peak during puberty, and a laboratory range keyed to birthday age rather than pubertal stage can flag a perfectly normal adolescent as high. The results that concern pediatric endocrinologists are those paired with an unusually fast growth rate, disproportionately large hands and feet, or coarsening facial features, which together raise the question of excess growth hormone. A pediatrician will look at the growth chart first, because the growth curve carries more information than a single laboratory value.
What is a normal IGFBP-3 range by age?
There is no single number that applies to everyone. Values are lowest in early childhood, climb steadily through childhood, peak during puberty, settle in young adulthood, and then decline gradually with age. Each laboratory publishes its own age-banded and sex-banded intervals based on the analyzer it uses, and those intervals genuinely differ between labs. This is why the age-adjusted standard deviation score is more useful than the raw figure, and why comparing a result to a range you found online is unreliable.
Can I raise my IGFBP-3 level naturally?
There is no supplement or food shown to raise this protein safely and predictably in a healthy person, and deliberately pushing the growth axis is not a recognized health goal. What does support the axis is correcting what suppressed it: adequate calories and protein, treatment of an underlying liver, kidney, or intestinal condition, better diabetes control, and enough sleep. Where a genuine deficiency of growth hormone is confirmed, the treatment is prescribed hormone replacement supervised by an endocrinologist, not an over-the-counter product.
Is a low IGFBP-3 in a child always growth hormone deficiency?
No. A low value narrows the possibilities but does not confirm a pituitary problem. Undernutrition, celiac disease, inflammatory bowel disease, chronic kidney or liver disease, hypothyroidism, and simply being a young child with naturally low values can all produce a low reading. That is why the diagnosis of growth hormone deficiency rests on the growth curve, on other blood tests, and usually on a stimulation test, rather than on this marker alone.
How does IGFBP-3 differ from IGF-1 on my report?
IGF-1 is the active messenger; IGFBP-3 is the vehicle carrying it. Because roughly three quarters or more of circulating IGF-1 is bound, the two usually move in the same direction. IGFBP-3 tends to be steadier across the day and less affected by a short fast, which makes it useful as a cross-check, especially in very young children where IGF-1 alone is hard to interpret. When the two disagree noticeably, that discrepancy itself is informative and prompts a closer look at nutrition, liver function, and the assay used.
Sources
- MedlinePlus, National Library of Medicine — IGF-1 (Insulin-like Growth Factor 1) Test — MedlinePlus Medical Test, reviewed 2024 — medlineplus.gov
- Cleveland Clinic — Growth Hormone Deficiency (GHD): Symptoms and Treatment — Cleveland Clinic Health Library — my.clevelandclinic.org
- Mayo Clinic — Acromegaly: Diagnosis and Treatment — Mayo Clinic Diseases and Conditions — mayoclinic.org
- Vilmann L, Albrethsen J, Petersen JH, et al. — Bioactive IGF-I Concentrations in Children on GH Therapy — The Journal of Clinical Endocrinology and Metabolism, 2026 — doi.org/10.1210/clinem/dgaf566
- Wang H, Wang X, Wang X, et al. — 24-Week jumping exercise influence on growth speed and GH-IGF-1-IGFBP-3 axis among short-stature children — BMC Pediatrics, 2025 — doi.org/10.1186/s12887-025-05821-3
- Lee JA, Wise J, Raudsepp SD, et al. — Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemia — European Heart Journal Open, 2025 — doi.org/10.1093/ehjopen/oeaf028
- Schweizer JROL, Schilbach K, Haenelt M, et al. — Soluble alpha klotho: impact of biological variables and reference intervals for adults — European Journal of Endocrinology, 2025 — doi.org/10.1093/ejendo/lvaf093
- Campos VC, Aguiar Oliveira MH, Bidlingmaier M, et al. — IGF-I bioavailability in congenital isolated growth hormone deficiency — European Journal of Endocrinology, 2026 — doi.org/10.1093/ejendo/lvag007
Further reading
- Compare the hormone that shapes growth in men and women by reading our testosterone blood level guide.
- Explore the estrogen marker that shifts pubertal and adult reference ranges with our estradiol blood test guide.
- Review the pituitary hormone most often checked alongside growth markers in our prolactin blood level guide.
- Check the nutrient that underpins bone growth and skeletal health with our vitamin D blood level guide.
- Understand why an abnormal number can appear without symptoms by reading our explanation of high blood test results with no symptoms.
Understand your lab results with BloodSense
A binding protein result only makes sense next to the rest of the picture: the growth factor it carries, the pituitary hormones checked with it, and the liver, kidney, and nutrition markers that quietly shape the number. BloodSense reads your report as a whole, translates each value into plain language, and shows you which findings are worth raising with your clinician. It helps you understand what you are looking at; it does not diagnose, and it does not replace your doctor.
